RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lotus Pharmaceuticals - Stock

Lotus Pharmaceuticals P/S 2024

Lotus Pharmaceuticals P/S

0

Ticker

LTUS

ISIN

US5457152032

WKN

A1H5XJ

As of Jul 7, 2024, Lotus Pharmaceuticals's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Lotus Pharmaceuticals P/S history

Lotus Pharmaceuticals Aktienanalyse

What does Lotus Pharmaceuticals do?

The company Lotus Pharmaceuticals Inc was founded in 1976 and is based in Taiwan. The company operates in the pharmaceutical products sector and currently employs approximately 1,100 employees. Over the years, the company has become one of the leading providers of medications in the Taiwanese market. Lotus Pharma's business model is focused on the production, marketing, and sale of pharmaceutical products for the Taiwanese market. The company operates a comprehensive research and development department that specializes in the development of new medications for specific therapeutic applications. This department is also responsible for the continuous improvement and adaptation of existing medications. Lotus Pharma operates a range of different divisions within its organization. These include the marketing and distribution of innovative and generic medications, the sale of medical devices, and the development and production of natural remedies. Each division is focused on a specific group of customers and products. Lotus Pharma's product offering includes a wide range of pharmaceutical products developed for various therapeutic applications. These include medications for the treatment of cardiovascular diseases, diabetes, cancer, infectious diseases, and other acute and chronic illnesses. All products have been developed and manufactured in accordance with applicable international quality standards. An important product of Lotus Pharma is the antithrombotic medication "Plavix," which is used to prevent blood clots in cases of heart attack and stroke. Lotus Pharma is the only authorized manufacturer of this medication for the Taiwanese market, giving it a strong market position in this area. In recent years, Lotus Pharma has also expanded its offering to include natural remedies. These are increasingly in demand by a growing number of people interested in alternative treatment methods. These products have all been developed based on traditional Chinese medicine principles and are based on natural ingredients. Lotus Pharma aims to improve the health and well-being of its customers. The company strives to offer high-quality pharmaceutical products that meet the needs of its customers and help them achieve their health goals. Through its comprehensive research and development efforts, as well as its top-notch production and marketing, Lotus Pharma has become a key player in the Taiwanese market and is expected to continue growing in the coming years. Lotus Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Lotus Pharmaceuticals's P/S Ratio

Lotus Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Lotus Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Lotus Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Lotus Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Lotus Pharmaceuticals stock

What is the price-to-earnings ratio of Lotus Pharmaceuticals?

The price-earnings ratio of Lotus Pharmaceuticals is currently 0.

How has the price-earnings ratio of Lotus Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Lotus Pharmaceuticals has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Lotus Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Lotus Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Lotus Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Lotus Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Lotus Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Lotus Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Lotus Pharmaceuticals?

Some factors that influence the price-earnings ratio of Lotus Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Lotus Pharmaceuticals pay?

Over the past 12 months, Lotus Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lotus Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Lotus Pharmaceuticals?

The current dividend yield of Lotus Pharmaceuticals is .

When does Lotus Pharmaceuticals pay dividends?

Lotus Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lotus Pharmaceuticals?

Lotus Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Lotus Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lotus Pharmaceuticals located?

Lotus Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lotus Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lotus Pharmaceuticals from 7/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/7/2024.

When did Lotus Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/7/2024.

What was the dividend of Lotus Pharmaceuticals in the year 2023?

In the year 2023, Lotus Pharmaceuticals distributed 0 USD as dividends.

In which currency does Lotus Pharmaceuticals pay out the dividend?

The dividends of Lotus Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lotus Pharmaceuticals

Our stock analysis for Lotus Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lotus Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.